JP7743217B2 - アトピー性皮膚炎の重症度の検出方法 - Google Patents

アトピー性皮膚炎の重症度の検出方法

Info

Publication number
JP7743217B2
JP7743217B2 JP2021114251A JP2021114251A JP7743217B2 JP 7743217 B2 JP7743217 B2 JP 7743217B2 JP 2021114251 A JP2021114251 A JP 2021114251A JP 2021114251 A JP2021114251 A JP 2021114251A JP 7743217 B2 JP7743217 B2 JP 7743217B2
Authority
JP
Japan
Prior art keywords
severity
atopic dermatitis
expression level
subject
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021114251A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022016416A (ja
JP2022016416A5 (enExample
Inventor
直人 高田
哲矢 桑野
高良 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of JP2022016416A publication Critical patent/JP2022016416A/ja
Publication of JP2022016416A5 publication Critical patent/JP2022016416A5/ja
Application granted granted Critical
Publication of JP7743217B2 publication Critical patent/JP7743217B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021114251A 2020-07-10 2021-07-09 アトピー性皮膚炎の重症度の検出方法 Active JP7743217B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020119040 2020-07-10
JP2020119040 2020-07-10

Publications (3)

Publication Number Publication Date
JP2022016416A JP2022016416A (ja) 2022-01-21
JP2022016416A5 JP2022016416A5 (enExample) 2025-02-18
JP7743217B2 true JP7743217B2 (ja) 2025-09-24

Family

ID=79552561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021114251A Active JP7743217B2 (ja) 2020-07-10 2021-07-09 アトピー性皮膚炎の重症度の検出方法

Country Status (5)

Country Link
US (1) US20230265515A1 (enExample)
EP (1) EP4180536A4 (enExample)
JP (1) JP7743217B2 (enExample)
CN (1) CN115803450A (enExample)
WO (1) WO2022009988A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279901A (zh) * 2020-03-11 2022-11-01 花王株式会社 来自皮肤表面脂质的rna的制备方法
WO2024232368A1 (ja) * 2023-05-08 2024-11-14 花王株式会社 アトピー性皮膚炎の重症度の検出方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005100602A (ja) 2003-08-26 2005-04-14 Matsushita Electric Ind Co Ltd 記録媒体の原盤製造方法、スタンパ製造方法、記録媒体製造方法、記録媒体の原盤、記録媒体のスタンパ、記録媒体
WO2018161062A1 (en) 2017-03-03 2018-09-07 Children's Hospital Medical Center Non-invasive methods for skin sample collection and analysis
JP2020074769A (ja) 2018-11-01 2020-05-21 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6006906B1 (ja) * 2016-03-25 2016-10-12 花王株式会社 皮脂腺又は毛包選択的アンドロゲン受容体活性制御剤の評価又は選択方法
EP3719138B1 (en) 2016-07-08 2022-09-21 Kao Corporation Method for preparing nucleic acid sample
KR101818672B1 (ko) * 2017-02-17 2018-01-16 가천대학교 산학협력단 아토피 피부염 진단용 조성물 및 상기 조성물을 이용한 아토피 피부염의 진단 방법
WO2021221138A1 (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
CN115605608A (zh) * 2020-05-14 2023-01-13 花王株式会社（Jp） 帕金森氏病的检测方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005100602A (ja) 2003-08-26 2005-04-14 Matsushita Electric Ind Co Ltd 記録媒体の原盤製造方法、スタンパ製造方法、記録媒体製造方法、記録媒体の原盤、記録媒体のスタンパ、記録媒体
WO2018161062A1 (en) 2017-03-03 2018-09-07 Children's Hospital Medical Center Non-invasive methods for skin sample collection and analysis
JP2020074769A (ja) 2018-11-01 2020-05-21 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IZUHARA K. et al.，Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Dis，International Journal of Molecular Sciences，2018年，Vol.19, No.1102，pp.1-16，doi:10.3390/ijms19041102

Also Published As

Publication number Publication date
WO2022009988A1 (ja) 2022-01-13
CN115803450A (zh) 2023-03-14
JP2022016416A (ja) 2022-01-21
US20230265515A1 (en) 2023-08-24
EP4180536A4 (en) 2024-08-07
EP4180536A1 (en) 2023-05-17

Similar Documents

Publication Publication Date Title
JP7849812B2 (ja) パーキンソン病の検出方法
JP7743239B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7762549B2 (ja) アトピー性皮膚炎の症度変化の検出方法
JP2022016416A (ja) アトピー性皮膚炎の重症度の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
JP7743289B2 (ja) アトピー性皮膚炎の症度の検出方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
WO2022220298A1 (ja) 乳幼児おむつ皮膚炎の症度の検出方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
JP7847451B2 (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
JP2023002298A (ja) 糖尿病指標値の検出方法
JP7750481B2 (ja) 内臓脂肪面積の検出方法
WO2022220299A1 (ja) 乳幼児顔湿疹の症度の検出方法
JP2023073134A (ja) ホットフラッシュの検出方法
JP2023073135A (ja) 更年期障害の重症度の検出方法
JP2023048811A (ja) 疲労の検出方法
JP2023045067A (ja) 不眠の検出方法
JP2023048810A (ja) 慢性ストレスレベルの検出方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250304

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250703

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250826

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250910

R150 Certificate of patent or registration of utility model

Ref document number: 7743217

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150